Menu
 
Research menu
Jump to menu

Publications:  Dr Helen Ross-Adams

Sangaralingam A, Dayem Ullah AZ, Marzec J, Gadaleta E, Nagano A, Ross-Adams H, Wang J, Lemoine NR et al.(2017). 'Multi-omic' data analysis using O-miner. Brief Bioinform
10.1093/bib/bbx080
https://qmro.qmul.ac.uk/xmlui/handle/123456789/36329
Lalonde E, Alkallas R, Chua MLK, Fraser M, Haider S, Meng A, Zheng J, Yao CQ et al.(2017). Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors. European Urology vol. 72, (1) 22-31.
10.1016/j.eururo.2016.10.013
Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, Egevad LA, Russell R et al.(2017). Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]. EBioMedicine vol. 17, 238-238.
10.1016/j.ebiom.2017.03.010
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35006
Luca B-A, Brewer DS, Edwards DR, Edwards S, Whitaker HC, Merson S, Dennis N, Cooper RA et al.(2017). DESNT: A Poor Prognosis Category of Human Prostate Cancer. European urology focus
10.1016/j.euf.2017.01.016
Dunning MJ, Vowler SL, Lalonde E, Ross-Adams H, Boutros P, Mills IG, Lynch AG, Lamb AD(2017). Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App. EBioMedicine vol. 17, 5-6.
10.1016/j.ebiom.2017.02.022
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34330
Ross-Adams H, Ball S, Lawrenson K, Halim S, Russell R, Wells C, Strand SH, Ørntoft TF et al.(2016). HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer. Oncotarget vol. 7, (46) 74734-74746.
10.18632/oncotarget.12543
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33483
Shaw GL, Whitaker H, Corcoran M, Dunning MJ, Luxton H, Kay J, Massie CE, Miller JL et al.(2016). The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer. European Urology vol. 70, (2) 214-218.
10.1016/j.eururo.2015.10.042
Marzec J, Mao X, Li M, Wang M, Feng N, Gou X, Wang G, Sun Z et al.(2016). A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population. Oncotarget vol. 7, (16) 21393-21403.
10.18632/oncotarget.7250
https://qmro.qmul.ac.uk/xmlui/handle/123456789/23707
Whitington T, Gao P, Song W, Ross-Adams H, Lamb AD, Yang Y, Svezia I, Klevebring D et al.(2016). Gene regulatory mechanisms underpinning prostate cancer susceptibility. Nature Genetics vol. 48, (4) 387-397.
10.1038/ng.3523
Ross-Adams H, Lamb AD(2016). The genetic classification of prostate cancer: What's on the horizon?. Future Oncology vol. 12, (6) 729-733.
10.2217/fon.15.352
Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, Egevad LA, Russell R et al.(2015). Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine vol. 2, (9) 1133-1144.
10.1016/j.ebiom.2015.07.017
Massie CE, Spiteri I, Ross-Adams H, Luxton H, Kay J, Whitaker HC, Dunning MJ, Lamb AD et al.(2015). HES5 silencing is an early and recurrent change in prostate tumourigenesis. Endocrine-Related Cancer vol. 22, (2) 131-144.
10.1530/ERC-14-0454
Bon H, Wadhwa K, Schreiner A, Osborne M, Carroll T, Ramos-Montoya A, Ross-Adams H, Visser M et al.(2015). Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer. Molecular Cancer Research vol. 13, (4) 620-635.
10.1158/1541-7786.MCR-13-0182-T
Ramos-Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano-Dalmau N, Massie CE, Boren J et al.(2014). HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network. EMBO Molecular Medicine vol. 6, (5) 651-661.
10.1002/emmm.201303581
Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning MJ, Halim S et al.(2014). Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: A retrospective cohort study. The Lancet Oncology vol. 15, (13) 1521-1532.
10.1016/S1470-2045(14)71021-6
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA et al.(2013). Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression (vol 22, pg 2520, 2013). HUMAN MOLECULAR GENETICS vol. 22, (20) 4239-4239.
10.1093/hmg/ddt334
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA et al.(2013). Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet vol. 22, (12) 2520-2528.
10.1093/hmg/ddt086
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurn-Little S, Ross-Adams H, Al Olama AA et al.(2013). Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Human Molecular Genetics vol. 22, (12) 2520-2528.
10.1093/hmg/ddt086
Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD et al.(2012). Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proceedings of the National Academy of Sciences of the United States of America vol. 109, (28) 11252-11257.
10.1073/pnas.1200853109
Bellenguez C, Bevan S, Gschwendtner A, Spencer CCA, Burgess AI, Pirinen M, Jackson CA, Traylor M et al.(2012). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nature Genetics vol. 44, (3) 328-333.
10.1038/ng.1081
Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, Bancroft E, Jhavar S et al.(2010). The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS ONE vol. 5, (10)
10.1371/journal.pone.0013363
Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, Ross-Adams H, Meitinger T, Wichmann E et al.(2009). Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Annals of Neurology vol. 65, (5) 531-539.
10.1002/ana.21590
Pasdar A, Ross-Adams H, Cumming A, Cheung J, Whalley L, St Clair D, MacLeod MJ(2006). Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. BMC Medical Genetics vol. 7,
10.1186/1471-2350-7-28
Return to top